Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP300945.RAdXkgViSrJtOgTpp-PT5TIObXN5ZKa-XO4iJ385acMx8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP300945.RAdXkgViSrJtOgTpp-PT5TIObXN5ZKa-XO4iJ385acMx8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP300945.RAdXkgViSrJtOgTpp-PT5TIObXN5ZKa-XO4iJ385acMx8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP300945.RAdXkgViSrJtOgTpp-PT5TIObXN5ZKa-XO4iJ385acMx8130_provenance.
- NP300945.RAdXkgViSrJtOgTpp-PT5TIObXN5ZKa-XO4iJ385acMx8130_assertion description "[We have previously shown that in the human prostate cancer cell line LN-CaP, 1,25-(OH)2D3 mediates an increase in cyclin-dependent kinase inhibitor p27Kip1 levels, inhibition of cyclin-dependent kinase 2 (Cdk2) activity, hypophosphorylation of retinoblastoma protein, and accumulation of cells in G1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300945.RAdXkgViSrJtOgTpp-PT5TIObXN5ZKa-XO4iJ385acMx8130_provenance.
- NP300945.RAdXkgViSrJtOgTpp-PT5TIObXN5ZKa-XO4iJ385acMx8130_assertion evidence source_evidence_literature NP300945.RAdXkgViSrJtOgTpp-PT5TIObXN5ZKa-XO4iJ385acMx8130_provenance.
- NP300945.RAdXkgViSrJtOgTpp-PT5TIObXN5ZKa-XO4iJ385acMx8130_assertion SIO_000772 12954644 NP300945.RAdXkgViSrJtOgTpp-PT5TIObXN5ZKa-XO4iJ385acMx8130_provenance.
- NP300945.RAdXkgViSrJtOgTpp-PT5TIObXN5ZKa-XO4iJ385acMx8130_assertion wasDerivedFrom befree-20150227 NP300945.RAdXkgViSrJtOgTpp-PT5TIObXN5ZKa-XO4iJ385acMx8130_provenance.
- NP300945.RAdXkgViSrJtOgTpp-PT5TIObXN5ZKa-XO4iJ385acMx8130_assertion wasGeneratedBy ECO_0000203 NP300945.RAdXkgViSrJtOgTpp-PT5TIObXN5ZKa-XO4iJ385acMx8130_provenance.
- befree-20150227 importedOn "2015-02-27" NP300945.RAdXkgViSrJtOgTpp-PT5TIObXN5ZKa-XO4iJ385acMx8130_provenance.